DAVID P BROST
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical GREAT FALLS, MT NPI 1699757682
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical MT PFIZER INC. All categories
General Payments — all program years on this page
$4,176.32
- Category: General Payments
- Program years: PY2021–2024
- Record count: 240
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,587.19 across 87 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,364.74 | 84 |
| Education | $222.45 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $217.49 | 22 |
| EMD Serono, Inc. | $192.80 | 2 |
| Incyte Corporation | $166.81 | 7 |
| Merck Sharp & Dohme Corporation | $145.66 | 10 |
| Acerta Pharma LLC | $145.21 | 7 |
| Exelixis Inc. | $114.20 | 2 |
| Genentech USA, Inc. | $53.88 | 3 |
| ABBVIE INC. | $52.36 | 3 |
| Astellas Pharma US Inc | $49.37 | 3 |
| Daiichi Sankyo Inc. | $45.42 | 3 |
| Sumitomo Pharma America, Inc. | $41.37 | 2 |
| Janssen Biotech, Inc. | $36.83 | 2 |
| GENZYME CORPORATION | $32.05 | 2 |
| Rigel Pharmaceuticals, Inc. | $30.98 | 2 |
| Gilead Sciences, Inc. | $30.37 | 2 |
| Regeneron Healthcare Solutions, Inc. | $28.54 | 2 |
| AVEO Pharmaceuticals, Inc. | $28.38 | 2 |
| Kyowa Kirin, Inc. | $23.50 | 1 |
| EISAI INC. | $20.77 | 1 |
| Alnylam Pharmaceuticals Inc. | $15.98 | 1 |
| PharmaEssentia USA Corporation | $15.88 | 1 |
| Stemline Therapeutics Inc. | $15.09 | 1 |
| Blueprint Medicines Corporation | $15.08 | 1 |
| BeiGene USA, Inc. | $14.37 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.18 | 1 |
| Celgene Corporation | $14.02 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.48 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.12 | 1 |
By program year
Records — PY2024 (87)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.